P-BCMA-101 Tscm CAR-T Cells in the Treatment of Patients With Multiple Myeloma (MM)
Clinical trial NCT03288493 · TERMINATED
Trial details
- NCT number
- NCT03288493
- Sponsor
- Poseida Therapeutics, Inc.
- Status
- TERMINATED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2017-09-20
- Primary completion
- 2022-04-27
- Enrollment
- 105
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.